AIMS: MYH is a DNA glycosylase in the base excision repair pathway. Germ-line biallelic mutations in the MYH gene are associated with the development of multiple colorectal adenomas and colorectal carcinoma (CRC). A slightly increased risk of CRC is suggested in monoallelic MYH mutation carriers. The aim was to characterize the histopathological features of carcinomas from biallelics and monoallelics. METHODS AND RESULTS: Clinicopathological features of 57 colorectal carcinomas from 50 patients identified in familial CRC registries were recorded. These included 16 cancers from 14 MYH biallelics; 25 cancers from 22 MYH monoallelics; and 16 cancers from 14 controls. Carcinomas in biallelics demonstrated tubular, papillary or cribriform patterns as the predominant histological subtype, and main histological groups differed according to mutation status (P = 0.0053). All biallelic cancers were low grade, with high-grade tumours more common in monoallelics and controls (P = 0.002). Synchronous polyps were observed in 75% of biallelics, 33% of monoallelics and 43% of controls (P = 0.035). Serrated carcinoma was the predominant type in 12% (3/25) of the monoallelics but in none of the biallelics or controls. MYH immunohistochemistry failed to distinguish between groups. CONCLUSIONS: Neither pathological features nor immunohistochemistry could predict the MYH mutation status of CRCs in this study.
AIMS: MYH is a DNA glycosylase in the base excision repair pathway. Germ-line biallelic mutations in the MYH gene are associated with the development of multiple colorectal adenomas and colorectal carcinoma (CRC). A slightly increased risk of CRC is suggested in monoallelic MYH mutation carriers. The aim was to characterize the histopathological features of carcinomas from biallelics and monoallelics. METHODS AND RESULTS: Clinicopathological features of 57 colorectal carcinomas from 50 patients identified in familial CRC registries were recorded. These included 16 cancers from 14 MYH biallelics; 25 cancers from 22 MYH monoallelics; and 16 cancers from 14 controls. Carcinomas in biallelics demonstrated tubular, papillary or cribriform patterns as the predominant histological subtype, and main histological groups differed according to mutation status (P = 0.0053). All biallelic cancers were low grade, with high-grade tumours more common in monoallelics and controls (P = 0.002). Synchronous polyps were observed in 75% of biallelics, 33% of monoallelics and 43% of controls (P = 0.035). Serrated carcinoma was the predominant type in 12% (3/25) of the monoallelics but in none of the biallelics or controls. MYH immunohistochemistry failed to distinguish between groups. CONCLUSIONS: Neither pathological features nor immunohistochemistry could predict the MYH mutation status of CRCs in this study.
Authors: Mark A Jenkins; Marina E Croitoru; Neerav Monga; Sean P Cleary; Michelle Cotterchio; John L Hopper; Steven Gallinger Journal: Cancer Epidemiol Biomarkers Prev Date: 2006-02 Impact factor: 4.254
Authors: Paolo Peterlongo; Nandita Mitra; Ana Sanchez de Abajo; Miguel de la Hoya; Chiara Bassi; Lucio Bertario; Paolo Radice; Emily Glogowski; Khedoudja Nafa; Trinidad Caldes; Kenneth Offit; Nathan A Ellis Journal: Carcinogenesis Date: 2006-06-14 Impact factor: 4.944
Authors: Wade S Samowitz; Martha L Slattery; Carol Sweeney; Jennifer Herrick; Roger K Wolff; Hans Albertsen Journal: Mol Cancer Res Date: 2007-02-09 Impact factor: 5.852
Authors: Joana Cardoso; Lia Molenaar; Renee X de Menezes; Monique van Leerdam; Carla Rosenberg; Gabriela Möslein; Julian Sampson; Hans Morreau; Judith M Boer; Riccardo Fodde Journal: Cancer Res Date: 2006-03-01 Impact factor: 12.701
Authors: Rachel S van der Post; Carolien M Kets; Marjolijn J L Ligtenberg; Joannes H J M van Krieken; Nicoline Hoogerbrugge Journal: Virchows Arch Date: 2008-11-25 Impact factor: 4.064
Authors: M Ponz de Leon; E D L Urso; S Pucciarelli; M Agostini; D Nitti; L Roncucci; P Benatti; M Pedroni; S Kaleci; A Balsamo; C Laudi; C Di Gregorio; A Viel; G Rossi; T Venesio Journal: Tech Coloproctol Date: 2012-09-14 Impact factor: 3.781
Authors: Monika Morak; Barbara Heidenreich; Gisela Keller; Heather Hampel; Andreas Laner; Albert de la Chapelle; Elke Holinski-Feder Journal: Eur J Hum Genet Date: 2014-02-12 Impact factor: 4.246
Authors: Sean P Cleary; Michelle Cotterchio; Mark A Jenkins; Hyeja Kim; Robert Bristow; Roger Green; Robert Haile; John L Hopper; Loic LeMarchand; Noralane Lindor; Patrick Parfrey; John Potter; Ban Younghusband; Steven Gallinger Journal: Gastroenterology Date: 2008-12-27 Impact factor: 22.682
Authors: Maartje Nielsen; Noel F C C de Miranda; Marjo van Puijenbroek; Ekaterina S Jordanova; Anneke Middeldorp; Tom van Wezel; Ronald van Eijk; Carli M J Tops; Hans F A Vasen; Frederik J Hes; Hans Morreau Journal: BMC Cancer Date: 2009-06-15 Impact factor: 4.430